vTv Therapeutics Inc.

VTVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $86.6M $98.1M $88.9M $98.5M $25.9M $31.1M $36.7M $41.6M
Accounts Receivable $62.0K $242.0K
Inventory
Total Current Assets $87.6M $98.8M $89.9M $99.5M $26.4M $31.9M $38.1M $43.0M
Property, Plant & Equipment $14.0K $16.0K $19.0K $28.0K $50.0K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $87.6M $98.8M $89.9M $99.5M $26.4M $32.0M $38.3M $43.2M
Liabilities
Accounts Payable $1.1M $939.0K
Total Current Liabilities $7.0M $6.9M $6.6M $10.2M $5.3M $4.3M $5.2M $6.4M
Long-Term Debt
Total Liabilities $9.0M $8.9M $25.5M $29.0M $24.0M $23.1M $24.0M $25.3M
Stockholders' Equity
Retained Earnings $-315.6M $-302.6M $-326.7M $-319.6M $-310.9M $-304.8M $-299.7M $-296.1M
Total Stockholders' Equity $78.6M $90.0M $64.4M $70.5M $2.8M $7.9M $12.2M $15.0M
← Newer Page 1 of 6 Older →